Lepirudin use in a neonate with heparin-induced thrombocytopenia

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 229-233

  Nguyen, Thuy N ^a   Gal, Peter ^b   Ransom, J Laurence ^c   Carlos, Rita ^c   Feliú, Juan F ^c   Marcotte, Alain ^c  

^a The Women's Hospital of Greensboro   (United States)

^b MOSES CONE HEALTH SYSTEM   (United States)

^c NONE

Author keywords

Danaparoid; Heparin induced; Lepirudin; Neonate; Thrombocytopenia

Indexed keywords

BLOOD CLOTTING FACTOR 10A; DANAPAROID; HEPARIN; LEPIRUDIN;

ARTICLE; BLOOD VOLUME; CASE REPORT; HUMAN; INFANT; LABORATORY TEST; MALE; PARTIAL THROMBOPLASTIN TIME; PREMATURITY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0037312557     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700214     Document Type: Article

References (19)

1. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119(suppl):344S-70S.
2. Ranze O, Ranze P, Magnani HN, Greinacher A. Heparin-induced thrombocytopenia in paediatric patients - a review of the literature and a new case treated with danaparoid sodium. Eur J Pediatr 1999;158(suppl):S130-3.
3. Spadone D, Clark F, James E, Laster J, Hoch J, Silver D. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992;15:306-12.
4. Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002;109:E10.
5. Neuhaus TJ, Goetschel P, Schmugge M, Leumann E. Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid. Pediatr Nephrol 2000;14:713-6.
6. Dager WE, White RH. Treatment of heparin-induced thrombocytopenia. Ann Pharmacother 2002;36:489-503.
7. Fabris F, Ahmad S, Cella G, Jeske WP, Walenga JM, Fareed J. Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications - a review. Arch Pathol Lab Med 2000;124:1657-66.
8. Look K, Sahud M, Flaherty S, Zehner J. Heparin-platelet aggregation vs. platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol 1997;108:78-82.
9. Acostamadiedo JM, Iyer UG, Owen J. Danaparoid sodium. Exp Opin Pharmacother 2000;1:803-14.
10. Deitcher SR, Topoulos AP, Bartholomew JR, Kichuk-Chrisant MR. Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 2002;140:264-6.
11. Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, et al. Comparison of PF4/heparin ELISA with the 14-C serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104:648-54.
12. Severin T, Sutor AH. Heparin-induced thrombocytopenia in pediatrics. Semin Thromb Hemost 2001;27:293-9.
13. Zohrer B, Zenz W, Rattenbacher A, Covi P, Kurnik K, Kroll H, et al. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Acta Paediatr 2001;90:765-71.
14. Danaparoid sodium. In: McEvoy GK, ed. AHFS drug information 2001. Bethesda, MD: American Society of Health-System Pharmacists, 2001:1427-8.
15. Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Grubl Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997;99:273-80.
16. Greinacher A, Eichlar P, Lubenow N, Kwasny H, Luz M. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 2000;96:846-51.
17. Greinacher A, Lubenow N. Recombinant hirudin in clinical practice: focus on lepirudin. Circulation 2000;103:1479-84.
18. Greinacher A, Janssens U, Berg G, Bock M, Kwasny H, Kemkes-Mantthes B, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999;100:587-93.
19. Mudaliar JH, Liem TK, Nichols WK, Spadone DP, Silver D. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. J Vasc Surg 2001;34:17-20.